The MAST program advances new drugs, devices and therapies for patients with gastrointestinal and metabolic diseases.
Deepening Comprehension of Digestive Diseases
Research breakthroughs in gut microbiome and other digestive diseases help experts improve diagnostic tools and protocols.Read More
Making Diabetes Easier to Treat
New insights into bariatric surgery, insulin pump technology, microbiome connection and insulin clearance present opportunities for diabetes research and treatments.Read More
New Breath Test Diagnostics
Irritable bowel syndrome and small intestinal bacterial overgrowth have similar symptoms yet require different treatments—a new test can provide more accurate diagnosis.Read More
Patient Feature: Dreaming of Wellness
After years of misdiagnosis for her pain, Pam Emmer traveled from her home in the Midwest to Cedars-Sinai with the hope of finding a cure.Read More
Mark Pimentel, MD
"Discovery best happens at the bedside of patients by doctors and not just in a pharmaceutical lab."
How microorganisms contribute to disease
This clinical trial examines how gut microbes may be affected by genetics to understand how gut microorganisms contribute to gut-related diseases.Learn More